PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 8, 2026PLoS neglected tropical diseases0 citationsOpen Access

National control programs for scabies: Experiences from Fiji and Solomon Islands

SASarah AnderssonMPMatthew ParnabySLSusanna Lake

Key Points

  • The aim is to document the experiences from Fiji and Solomon Islands in implementing mass drug administration for scabies control.
  • Established the World Scabies Program in partnership with local health ministries.
  • Implemented ivermectin-based mass drug administration in highly endemic areas.
  • Adapted strategies to address challenges posed by the COVID-19 pandemic.
  • Mass drug administration has shown potential for improved health outcomes if large populations are reached.
  • Addressing misconceptions about scabies improved health worker motivation and program uptake.
  • Integration with other health programs enhanced affordability and acceptability.

Abstract

Introduction The most recent World Health Organization roadmap for neglected tropical diseases sets a target for countries to control scabies through several interventions, including mass drug administration in endemic areas where prevalence is 10% or greater using oral ivermectin and topical scabicides. This report documents the experiences and lessons learned from the first two countries in the world, Fiji and Solomon Islands, to implement national ivermectin-based mass drug administration for scabies. By identifying key challenges, this article aims to inform the global community as efforts are established to reach these targets. Program description The World Scabies Program was established by the Murdoch Children’s Research Institute in 2019, with the Kirby Institute at the University of New South Wales and the Ministries of Health in Fiji and Solomon Islands as key partners. The Program aims to translate research findings from studies of ivermectin-based mass drug administration into national scabies control programs in Fiji and Solomon Islands. Lessons learned The Program adapted to meet several challenges. The COVID-19 pandemic restricted travel by Program staff, necessitating greater local autonomy. Addressing local misconceptions of scabies improves uptake and health worker motivation. Integrating with other neglected tropical diseases and health programs improved affordability and acceptability of the Program. New strategies are required to reach urban populations, and pragmatic dosing options across all ages would increase feasibility. Conclusions The implementation of scabies mass drug administration in highly endemic areas has the potential to lead to substantial improvements in health outcomes if large populations are reached. The impact of the mass drug administration campaigns in Fiji and Solomon Islands remains to be fully evaluated, but we have already learnt critical lessons to inform future efforts towards scabies control.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Andersson et al. (2026) studied this question.

synapsesocial.com/papers/698828ab0fc35cd7a884856chttps://doi.org/10.1371/journal.pntd.0013874
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Scabies and impetigo prevalence following ivermectin-based mass drug administration campaigns in Solomon Islands and Fiji2026
  2. 2Why does treatment for scabies fail?2024 · 4 citations
  3. 3Ivermectin-based mass drug administration for scabies in northern India: a single-arm community intervention trial2024
  4. 4Investigation and response to a scabies outbreak in a rural community in Biakoye District Ghana May 20252025
  5. 5Scabies: current knowledge and future directions2024 · 17 citations